Status:
UNKNOWN
Role of Tzanck Smear in Determining Pemphigus Vulgaris Disease Activity
Lead Sponsor:
Istanbul Medeniyet University
Conditions:
Pemphigus Vulgaris
Eligibility:
All Genders
18+ years
Brief Summary
Aim: Pemphigus vulgaris (PV) is a rare, life-threatening autoimmune bullous disease that can involve the skin and mucous membranes, characterized by intraepidermal bullae and eroded lesions caused by ...
Eligibility Criteria
Inclusion
- Clinical, histopathological and immunological diagnosis of pemphigus vulgaris
- Must be active bullae or erosion at any stage of the disease
Exclusion
- Patients with uncertain diagnosis of pemphigus vulgaris
- Eroded lesions due to causes other than pemphigus vulgaris (such as herpes in the oral mucosa, candida infection)
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 15 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05338112
Start Date
January 1 2022
End Date
April 15 2023
Last Update
March 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Medeniyet University
Istanbul, Turkey (Türkiye)